Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients
拉帕替尼联合卡培他滨治疗HER2阳性晚期乳腺癌：来自中国患者的疗效、安全性和生物标志物结果
期刊:Chinese Journal of Cancer
影响因子:
doi:10.5732/cjc.010.10507
Xu, Bing-He; Jiang, Ze-Fei; Chua, Daniel; Shao, Zhi-Min; Luo, Rong-Cheng; Wang, Xiao-Jia; Liu, Dong-Geng; Yeo, Winnie; Yu, Shi-Ying; Newstat, Beth; Preston, Alka; Martin, Anne-Marie; Chi, Hai-Dong; Wang, Li
